About Juvena

  • Juvena Therapeutics is a venture-backed biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases. 
  • We are achieving this through an Artificial Intelligence-enabled platform that combines a compounding database mapping secreted proteins to specific disease phenotypes, an in silico screening technology, wetlab screening in primary human cell and animal models, and protein engineering capabilities. 
  • Our goal is to use this integrated platform to accelerate the development of regenerative biologics.
image of secreted proteins

Meet the Team

We’ve brought together a team of brilliant minds to unlock the brilliance of the human body.

Join Our Team

Be part of the team that’s decoding secreted proteins to improve human health

Recent News

November 8, 2022

The Wall Street Journal Discusses Juvena’s Series A and Its Potential to Expand the Range of Treatments for Chronic Conditions and Disease of Aging

Read More »
November 8, 2022

Juvena Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases

Read More »